ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 93 filers reported holding ARCUS BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,563 | -100.0% | 142,800 | -48.2% | 0.00% | -55.6% |
| Q2 2021 | $7,571,000 | +4.9% | 275,700 | +7.3% | 0.01% | 0.0% |
| Q1 2021 | $7,214,000 | +98.8% | 256,900 | -1.7% | 0.01% | +125.0% |
| Q1 2020 | $3,628,000 | +65.4% | 261,416 | +20.3% | 0.00% | +100.0% |
| Q4 2019 | $2,194,000 | +71.1% | 217,238 | +54.2% | 0.00% | +100.0% |
| Q3 2019 | $1,282,000 | +366.2% | 140,838 | +307.0% | 0.00% | – |
| Q2 2019 | $275,000 | – | 34,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |